The Role of Breast Cancer Resistance Protein in Acute Lymphoblastic Leukemia

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5171-5177

  Plasschaert, Sabine L A ^a   Van Der Kolk, Dorina M ^a   De Bont, Eveline S J M ^a   Kamps, Willem A ^a   Morisaki, Kuniaki ^d   Bates, Susan E ^c   Scheffer, George L ^b   Scheper, Rik J ^b   Vellenga, Edo ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BREAST CANCER RESISTANCE PROTEIN; CYTOSTATIC AGENT; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; MITOXANTRONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BXP 34; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; TOPOTECAN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER RESISTANCE; CELL LINEAGE; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; INFANT; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, T-CELL, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PROPIONATES; QUINOLINES; TUMOR CELLS, CULTURED;

EID: 10744230207     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Chessells, J. M., Hall, E., Prentice, H. G., Durrant, J., Bailey, C. C., and Richards, S. M. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia (Baltimore), 12: 463-473, 1998.
2. Mauer, A. M. Adult and childhood acute lymphocytic leukemia: are they different diseases? Am. J. Hematol., 42: 127-131, 1993.
3. den Boer, M. L., Pieters, R., Kazemier, K. M., Rottier, M. M., Zwaan, C. M., Kaspers, G. J., Janka-Schaub, G., Henze, G., Creutzig, U., Scheper, R. J., and Veerman, A. J. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood, 91: 2092-2098, 1998.
4. Dhooge, C., De Moerloose, B., Laureys, G., Kint, J., Ferster, A., De Bacquer, D., Philippe, J., and Benoit, Y. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study. Br. J. Haematol., 105: 676-683, 1999.
5. Goasguen, J. E., Dossot, J. M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P. Y., Chaperon, J., and Fauchet, R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81: 2394-2398, 1993.
6. Ivy, S. P., Olshefski, R. S., Taylor, B. J., Patel, K. M., and Reaman, G. H. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. Blood, 88: 309-318, 1996.
7. Wattel, E., Lepelley, P., Merlat, A., Sartiaux, C., Bauters, F., Jouet, J. P., and Fenaux, P. Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment. Leukemia (Baltimore), 9: 1870-1874, 1995.
8. Wuchter, C., Leonid, K., Ruppert, V., Schrappe, M., Buchner, T., Schoch, C., Haferlach, T., Harbott, J., Ratei, R., Dorken, B., and Ludwig, W. D. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and over-all survival in acute leukemia. Haematologica, 85: 711-721, 2000.
9. Plasschaert, S. L. A., Vellenga, E., de Bont, E. S. J. M., van der Kolk, D. M., Veerman, A. J., Sluiter, W. J., Daenen, S. M. G., de Vries, E. G. E., and Kamps, W. A. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukemic cells in adults than in children. Leuk. Lymphoma, 44: 85-95, 2002.
10. Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V., and Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58: 5337-5339, 1998.
11. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670, 1998.
12. Rabindran, S. K., He, H., Singh, M., Brown, E., Collins, K. I., Annable, T., and Greenberger, L. M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res., 58: 5850-5858, 1998.
13. Maliepaard, M., van Gastelen, M. A., Tohgo, A., Hausheer, F. H., van Waardenburg, R. C., de Jong, L. A., Pluim, D., Beijnen, J. H., and Schellens, J. H. Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Clin. Cancer Res., 7: 935-941, 2001.
14. Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., and Bates, S. E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci., 113: 2011-2021, 2000.
15. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., Schinkel, A. H., van De Vijver, M. J., Scheper, R. J., and Schellens, J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res., 61: 3458-3464, 2001.
16. Consoli, U., Van, N. T., Neamati, N., Mahadevia, R., Beran, M., Zhao, S., and Andreeff, M. Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines. Leukemia (Baltimore), 11: 2066-2074, 1997.
17. Schneider, E., Horton, J. K., Yang, C. H., Nakagawa, M., and Cowan, K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res., 54: 152-158, 1994.
18. Diah, S. K., Smitherman, P. K., Aldridge, J., Volk, E. L., Schneider, E., Townsend, A. J., and Morrow, C. S. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Res., 61: 5461-5467, 2001.
19. Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Perez, W. Y., Robey, R. W., van de, L. A., Litman, T., Dean, M., and Bates, S. E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res., 61: 6635-6639, 2001.
20. Volk, E. L., Farley, K. M., Wu, Y., Li, F., Robey, R. W., and Schneider, E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res., 62: 5035-5040, 2002.
21. van der Kolk, D. M., Vellenga, E., Scheffer, G. L., Müller, M., Bates, S. E., Scheper, R. J., and de Vries, E. G. Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood, 99: 3763-3770, 2002.
22. Robey, R. W., Honjo, Y., van de Laar, A., Miyake, K., Regis, J. T., Litman, T., and Bates, S. E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta, 1512: 171-182, 2001.
23. Scharenberg, C. W., Harkey, M. A., and Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 99: 507-512, 2002.
24. Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., and Sorrentino, B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med., 7: 1028-1034, 2001.
25. Kamps, W. A., Veerman, A. J., van Wering, E. R., van Weerden, J. F., Slater, R., and Does-van den Berg, A. Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991. Leukemia (Baltimore), 14: 2240-2246, 2000.
26. Daenen, S., van Imhoff, G. W., van den Berg, E., de Kam, P. J., Haaxma-Reiche, H., Vellenga, E., Smit, J. W., and Halie, R. M. Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a 'preinduction' course for rapid tumour reduction: preliminary results on 66 patients. Br. J. Haematol., 100: 273-282, 1998.
27. Scheffer, G. L., Maliepaard, M., Pijnenborg, A. C., van Gastelen, M. A., de Jong, M. C., Schroeijers, A. B., van der Kolk, D. M., Allen, J. D., Ross, D. D., van der Valk, P., Dalton, W. S., Schellens, J. H., and Scheper, R. J. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res., 60: 2589-2593, 2000.
28. Jones, T. R., Zamboni, R., Belley, M., Champion, E., Charette, L., Ford-Hutchinson, A. W., Frenette, R., Gauthier, J. Y., Leger, S., Masson, P., et al. Pharmacology of L-660, 711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Cancer J. Physiol. Pharmacol., 67: 17-28, 1989.
29. van der Kolk, D. M., de Vries, E. G., Koning, J. A., van den Berg, E., Müller, M., and Vellenga, E. Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. Clin. Cancer Res., 4: 1727-1736, 1998.
30. Sauerbrey, A., Sell, W., Steinbach, D., Voigt, A., and Zintl, F. Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia. Br. J. Haematol., 118: 147-150, 2002.
31. Chaudhary, P. M., and Roninson, I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66: 85-94, 1991.
32. Bunting, K. D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells, 20: 11-20, 2002.
33. Laupeze, B., Amiot, L., Drenou, B., Bernard, M., Branger, B., Grosset, J. M., Lamy, T., Fauchet, R., and Fardel, O. High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival. Br. J. Haematol., 116: 834-838, 2002.
34. Legrand, O., Simonin, G., Perrot, J. Y., Zittoun, R., and Marie, J. P. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood, 91: 4480-4488, 1998.
35. te Boekhorst, P. A., de Leeuw, K., Schoester, M., Wittebol, S., Nooter, K., Hagemeijer, A., Löwenberg, B., and Sonneveld, P. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood, 82: 3157-3162, 1993.
36. van der Kolk, D. M., de Vries, E. G., Noordhoek, L., van den Berg, E., van der Pol, M. A., Müller, M., and Vellenga, E. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. Leukemia (Baltimore), 15: 1544-1553, 2001.
37. Cascavilla, N., Musto, P., D'Arena, G., Ladogana, S., Matera, R., and Carotenuto, M. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression. Haematologica, 82: 31-37, 1997.
38. Minderman, H., Suvannasankha, A., O'Loughlin, K. L., Scheffer, G. L., Scheper, R. J., Robey, R. W., and Baer, M. R. Flow cytometric analysis of breast cancer resistance protein expression and function. Cytometry, 48: 59-65, 2002.
39. Broxterman, H. J., Sonneveld, P., Feller, N., Ossenkoppele, G. J., Wahrer, D. C., Eekman, C. A., Schoester, M., Lankelma, J., Pinedo, H. M., Lowenberg, B., and Schuurhuis, G. J. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood, 87: 4809-4816, 1996.
40. Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910. 1994.